Treatment of Rats With an Anti-(+)-Methamphetamine Monoclonal Antibody Shortens the Duration of Action of Repeated (+)-Methamphetamine Challenges Over a One Month Period

Vaccine - Netherlands
doi 10.1016/j.vaccine.2014.09.025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Functional and Biological Determinants Affecting the Duration of Action and Efficacy of Anti-(+)-Methamphetamine Monoclonal Antibodies in Rats

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2009English

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Treatment of Methamphetamine Induced Persistent Psychosis

Journal of Addiction and Preventive Medicine
2016English

Buflomedil Interference With the Monoclonal EMIT D. A. U. Amphetamine/ Methamphetamine Immunoassay

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
1997English

The Monoacylglycerol Lipase Inhibitor JZL184 Attenuates Methamphetamine-Seeking Behaviors in Methamphetamine Self-Administered Rats

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Perseverative Behavior in Rats With Methamphetamine-Induced Neurotoxicity

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2013English

Topiramate for the Treatment of Methamphetamine Addiction: A Meta-Analysis

Journal of Alcoholism & Drug Dependence
2018English

The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Long-Term Delivery of an Anti-Siv Monoclonal Antibody With AAV

Frontiers in Immunology
AllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy